Cinclus Pharma Holding AB () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Cinclus Pharma Holding AB

Why is Cinclus Pharma Holding AB ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

125.60%

EBIT Growth (5y)

-224.94%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.62

EV to EBIT

-1.03

EV to EBITDA

-1.03

EV to Capital Employed

-1.48

EV to Sales

37.87

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-35.91%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

NET SALES(HY)

At SEK 23.38 MM has Grown at 410.39%

NET PROFIT(HY)

Higher at SEK -101.85 MM

-10What is not working for the Company

RAW MATERIAL COST(Y)

Grown by 101.09% (YoY

OPERATING PROFIT(Q)

Lowest at SEK -61.05 MM

PRE-TAX PROFIT(Q)

Lowest at SEK -61.14 MM

NET PROFIT(Q)

Lowest at SEK -61.18 MM

EPS(Q)

Lowest at SEK -1.31

Here's what is working for Cinclus Pharma Holding AB

Net Sales

At SEK 23.38 MM has Grown at 410.39%

Year on Year (YoY)

MOJO Watch

Sales trend is very positive

Net Sales (SEK MM)

Here's what is not working for Cinclus Pharma Holding AB

Pre-Tax Profit

At SEK -61.14 MM has Fallen at -38.42%

over average net sales of the previous four periods of SEK -44.17 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (SEK MM)

Net Profit

At SEK -61.18 MM has Fallen at -38.23%

over average net sales of the previous four periods of SEK -44.26 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (SEK MM)

Operating Profit

Lowest at SEK -61.05 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (SEK MM)

Pre-Tax Profit

Lowest at SEK -61.14 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (SEK MM)

Net Profit

Lowest at SEK -61.18 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (SEK MM)

EPS

Lowest at SEK -1.31

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (SEK)

Raw Material Cost

Grown by 101.09% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales